John Wiley & Sons, Inc. Share Price

Equities

WLY

US9682232064

Professional Information Services

Market Closed - Nyse 21:00:02 26/04/2024 BST 5-day change 1st Jan Change
38.35 USD +1.05% Intraday chart for John Wiley & Sons, Inc. +2.18% +20.83%
Sales 2024 * 1.84B 148B Sales 2025 * 1.65B 132B Capitalization 2.1B 168B
Net income 2024 * -191M -15.29B Net income 2025 * 126M 10.09B EV / Sales 2024 * 1.14 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 1.27 x
P/E ratio 2024 *
-11 x
P/E ratio 2025 *
16.5 x
Employees 8,800
Yield 2024 *
-
Yield 2025 *
-
Free-Float 50.8%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.05%
1 week+2.18%
Current month+0.58%
1 month+3.85%
3 months+9.10%
6 months+28.18%
Current year+20.83%
More quotes
1 week
37.33
Extreme 37.3282
38.77
1 month
35.94
Extreme 35.94
39.84
Current year
30.45
Extreme 30.45
39.84
1 year
28.84
Extreme 28.835
40.23
3 years
28.84
Extreme 28.835
66.04
5 years
28.84
Extreme 28.835
66.04
10 years
28.84
Extreme 28.835
71.75
More quotes
Managers TitleAgeSince
Chief Executive Officer 70 31/12/02
Chairman 54 31/12/02
Director of Finance/CFO 53 21/11/21
Members of the board TitleAgeSince
Director/Board Member 73 30/04/98
Director/Board Member 67 31/08/14
Director/Board Member 66 31/12/04
More insiders
Date Price Change Volume
26/04/24 38.35 +1.05% 255,240
25/04/24 37.95 -1.12% 177,984
24/04/24 38.38 -0.83% 178,082
23/04/24 38.7 +1.60% 198,488
22/04/24 38.09 +1.49% 262,278

Delayed Quote Nyse, April 26, 2024 at 09:00 pm

More quotes
John Wiley & Sons, Inc. is a knowledge company. The Company is engaged in providing research, publishing, and knowledge solutions. The Company's segments include Research, Learning, and Held for Sale or Sold. Research segment is a provide peer-reviewed scientific, technical, and medical (STM) publishing, content platforms, and related services to academic, corporate, and government customers, academic societies, and individual researchers. The Learning segment provides scientific, professional, and education print and digital books, digital courseware to libraries, corporations, students, professionals, and researchers, as well as assessment services to businesses and professionals. The Company's Research Publishing products provide scientific, technical, medical, and scholarly journals, as well as related content and services, to academic, corporate, and government libraries, learned societies, and individual researchers, and other professionals.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
38.35 USD
Average target price
50 USD
Spread / Average Target
+30.38%
Consensus